FDA Discussing Guidance On Giving Drug Economic Data To Formulary Managers
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA official Tom Abrams recently acknowledged heightened stakeholder interest in guidance on appropriate communications of health care economic data under FDAMA Sec. 114.